MEDP — Medpace Holdings, Inc.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1668397 ·
Last close
$615.94
Market Cap
$17.19B
52W High
$677.90
52W Low
$373.00
ADV30
222,808
Next earnings
2026-10-21
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 706,604,000 | 196,326,000 | 141,503,000 | 123,870,000 | 2,129,613,000 | 652,681,000 | 1,531,299,000 |
| Dec 2025 | 708,450,000 | 205,316,000 | 153,269,000 | 135,133,000 | 1,975,472,000 | 497,049,000 | 1,516,401,000 |
| Sep 2025 | 659,903,000 | 196,939,000 | 141,808,000 | 111,135,000 | 1,753,012,000 | 285,351,000 | 1,459,371,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$752,660,000
Investing CF
$-45,766,000
Financing CF
$-249,528,000
CapEx
$-45,974,000
Dividends Paid
—
Buybacks
$-299,338,000
EPS Diluted TTM
$17.06
As of
2026-07-26
Balance + Analyst (yfinance extras)
Retained Earnings
$-511,368,000
Inventory
—
Receivables
$441,797,000
ST Investments
—
EBIT TTM
$583,404,000
Pretax Income TTM
$598,923,000
Interest Exp TTM
—
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,782,287,872
EBITDA
$611,200,000
Free Cash Flow
$510,396,512
Enterprise Value
$16,040,079,360
Total Cash
$502,688,000
Total Debt
$144,112,000
Shares Out
27,911,655
Trailing EPS
$17.05
Book Value
$15.54
ROE
162.2%
ROA
20.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,530,234,000 | 534,935,000 | 451,123,000 | 1,975,472,000 | 1,516,401,000 | 459,071,000 | 713,223,000 |
| Dec 2024 | 2,109,054,000 | 446,870,000 | 404,386,000 | 2,100,866,000 | 1,275,321,000 | 825,545,000 | 608,815,000 |
| Dec 2023 | 1,885,842,000 | 336,825,000 | 282,810,000 | 1,656,828,000 | 1,097,878,000 | 558,950,000 | 433,374,000 |
| Dec 2022 | 1,459,996,000 | 278,697,000 | 245,368,000 | 1,352,495,000 | 966,108,000 | 386,387,000 | 388,050,000 |
TTM Snapshot
Revenues TTM
$1,968,130,000
NetIncome TTM
$347,598,000
OpCashFlow TTM
$0
Assets (Latest)
$1,975,472,000
Forward EPS
$19.31
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $620.00 · spot: $615.94 · call volume: 64 · put volume: 212
Expected Move to 2026-10-16:
±$46.50
(7.55%) —
implied range
$569.44 –
$662.44
· ATM straddle on $620.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $14.19B | $294.59 | — |
| ICLR | ICON PLC | $13.55B | $175.57 | — |
| INCY | INCYTE CORP | $25.30B | $124.82 | — |
| IDXX | IDEXX LABORATORIES INC /DE | $41.68B | $529.06 | — |
| IQV | IQVIA HOLDINGS INC. | $44.60B | $270.97 | — |
News headlines (Yahoo Finance, 1h cache)
CON or MEDP: Which Is the Better Value Stock Right Now?
2026-09-28 14:40 · Yahoo
Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026
2026-09-22 20:05 · Yahoo
Projected EPS and Revenue Gains Might Change The Case For Investing In Medpace Holdings (MEDP)
2026-09-22 04:33 · Yahoo
Medpace Holdings (MEDP) Nears Earnings, Is The Stock Fully Valued?
2026-09-22 03:25 · Yahoo
Medpace (MEDP) Outperforms Broader Market: What You Need to Know
2026-09-21 22:15 · Yahoo
Medpace (MEDP) Ascends While Market Falls: Some Facts to Note
2026-09-14 22:15 · Yahoo
Medpace Stock Hovers Near Entry, Offers Second Chance After July Spike
2026-08-26 17:21 · Yahoo
CON vs. MEDP: Which Stock Should Value Investors Buy Now?
2026-08-26 15:40 · Yahoo
What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock
2026-08-26 11:13 · Yahoo
Why Is Medpace (MEDP) Up 1.1% Since Last Earnings Report?
2026-08-21 15:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.